111 related articles for article (PubMed ID: 9861264)
21. Ivermectin and onchocerciasis: is it all solved?
Hopkins AD
Eye (Lond); 2005 Oct; 19(10):1057-66. PubMed ID: 16304585
[TBL] [Abstract][Full Text] [Related]
22. Where would I be without ivermectin? Capturing the benefits of community-directed treatment with ivermectin in Africa.
Okeibunor JC; Amuyunzu-Nyamongo M; Onyeneho NG; Tchounkeu YF; Manianga C; Kabali AT; Leak S
Trop Med Int Health; 2011 May; 16(5):608-21. PubMed ID: 21395925
[TBL] [Abstract][Full Text] [Related]
23. Involvement of women in community-directed treatment with ivermectin for the control of onchocerciasis in Rukungiri district, Uganda: a knowledge, attitude and practice study.
Katabarwa MN; Habomugisha P; Ndyomugyenyi R; Agunyo S
Ann Trop Med Parasitol; 2001 Jul; 95(5):485-94. PubMed ID: 11487370
[TBL] [Abstract][Full Text] [Related]
24. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
[TBL] [Abstract][Full Text] [Related]
25. [Mass treatment of onchocerciasis in 1996].
Chovet M; Carlier C; Queguiner P; Mariko S
Med Trop (Mars); 1995; 55(4 Pt 2):425-8. PubMed ID: 10906977
[TBL] [Abstract][Full Text] [Related]
26. Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment.
Makenga Bof JC; Maketa V; Bakajika DK; Ntumba F; Mpunga D; Murdoch ME; Hopkins A; Noma MM; Zouré H; Tekle AH; Katabarwa MN; Lutumba P
Trop Med Int Health; 2015 Jan; 20(1):48-62. PubMed ID: 25302560
[TBL] [Abstract][Full Text] [Related]
27. Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview.
Benton B
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S33-9. PubMed ID: 9861265
[TBL] [Abstract][Full Text] [Related]
28. [Partnerships and the distribution of Mectizan. The role of a non-governmental development organization in a country with endemic onchocerciasis].
Godin C
Sante; 1998; 8(1):62. PubMed ID: 9592883
[No Abstract] [Full Text] [Related]
29. A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings.
Ogbuagu KF; Eneanya CI
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S139-45. PubMed ID: 9861280
[TBL] [Abstract][Full Text] [Related]
30. [The placement of partnerships for Mectizan distribution systems].
Etya'ale D
Sante; 1998; 8(1):59-61. PubMed ID: 9592882
[No Abstract] [Full Text] [Related]
31. Using ivermectin-treatment coverage among schoolchildren monitored by schoolteachers as a proxy of population coverage in areas of Uganda where onchocerciasis is endemic.
Ndyomugyenyi R; Remme J
Ann Trop Med Parasitol; 2002 Jan; 96(1):53-60. PubMed ID: 11989535
[TBL] [Abstract][Full Text] [Related]
32. Problems and perspectives of managing an onchocerciasis control programme: a case study from Plateau state, Nigeria.
Miri ES
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S121-8. PubMed ID: 9861277
[TBL] [Abstract][Full Text] [Related]
33. [Parnerships and the distribution of Mectizan. The example of the onchocerciasis control program].
Mariko S
Sante; 1998; 8(1):64-5. PubMed ID: 9592885
[No Abstract] [Full Text] [Related]
34. Onchocerciasis control in Nigeria: will households be able to afford community-directed treatment with ivermectin?
Onwujekwe O; Shu E; Onwuameze O; Ndum C; Okonkwo P
Acta Trop; 2001 Dec; 80(3):277-81. PubMed ID: 11700186
[TBL] [Abstract][Full Text] [Related]
35. [Partnerships and the distribution of Mectizan. Ministries of health].
Ndoyo J
Sante; 1998; 8(1):66-7. PubMed ID: 9592886
[No Abstract] [Full Text] [Related]
36. African Programme for Onchocerciasis Control (APOC): sociological study in three foci of central Africa before the implementation of treatments with ivermectin (Mectizan).
Dimomfu BL; Lubeji DK; Noma M; Sékétéli A; Boussinesq M;
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):674-9. PubMed ID: 17433391
[TBL] [Abstract][Full Text] [Related]
37. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of the use of vector control and mass drug administration, separately or in combination, against lymphatic filariasis.
Krishnamoorthy K; Rajendran R; Sunish IP; Reuben R
Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S77-90. PubMed ID: 12625921
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria.
Onowhakpor AO; Okojie OH; Wagbatsoma VA
Indian J Public Health; 2017; 61(4):267-273. PubMed ID: 29219132
[TBL] [Abstract][Full Text] [Related]
40. [Ivermectin].
Boussinesq M
Med Trop (Mars); 2005; 65(1):69-79. PubMed ID: 15903082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
